Structural stability of diffusion barriers in thermoelectric SbTe: From first-principles calculations to experimental results 國立交通大學 Hsu, Hsiao-Hsuan; Cheng, Chun-Hu; Chiou, Shan-Haw; Huang, Chiung-Hui; Liu, Chia-Mei; Lin, Yu-Li; Chao, Wen-Hsuan; Yang, Ping-Hsing; Chang, Chun-Yen; Cheng, Chin-Pao
A randomized trial of compression first or analyze first strategies in patients with out-of-hospital cardiac arrest: Results from an Asian community 國立臺灣大學 Ma, Matthew Huei-Ming; Chiang, Wen-Chu; Ko, Patrick Chow-In; Yang, Chi-Wei; Wang, Hui-Chi; Chen, Shey-Ying; Chang, Wei-Tien; Huang, Chien-Hwa; Chou, Hao-Chang; Lai, Mei-Shu; Chien, Kuo-Long; Lee, Bin-Chou; Hwang, Chien-Hwa; Wang, Yao-Cheng; Hsiung, Guan-Hwa; Hsiao, Ying-Wen; Chang, Anna Marie; Chen, Wen-Jone; Chen, Shyr-Chyr; 王暉智; 張維典; 馬惠明; 陳世英; 柯昭穎; 黃建華; 賴美淑; 江文莒; 楊志偉; 陳文鍾; 陳石池; 簡國龍
AZD9291, a mutant-selective EGFR inhibitor, as first-line treatment for EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Results from a phase 1 expansion cohort. 國立臺灣大學 Ramalingam, Suresh S.; Yang, James Chih-Hsin; Lee, Chee Khoon; Kurata, Takayasu; Kim, Dong-Wan; John, Thomas; Nogami, Naoyuki; Ohe, Yuichiro; Rukazenkov, Yuri; Frewer, Paul; Cantarini, Mireille; Ghiorghiu, Serban; Janne, Pasi A.; 楊志新
Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study 國立臺灣大學 Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii; 鄭安理; 徐志宏